Phase 1b Study of CCX872-B in Patients With Pancreatic Adenocarcinoma


NCT02345408

Interventional

Phase 1

Active, not recruiting
This is an open-label phase 1-b study to evaluate the safety and efficacy of CCX872-B in patients with pancreatic adenocarcinoma also receiving FOLFIRINOX chemotherapy.
Feb 28,2015
All
18 Years
N/A
54

In order to facilitate the use of our website, we use cookies.

Please confirm if you accept our tracking cookies. When declining the cookies, you can continue visiting the website without sending data to third party services. Read our complete cookie statement here.